SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-066903
Filing Date
2024-03-13
Accepted
2024-03-13 16:49:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d745029ds3.htm S-3 395606
2 EX-1.2 d745029dex12.htm EX-1.2 180547
3 EX-4.2 d745029dex42.htm EX-4.2 284235
4 EX-5.1 d745029dex51.htm EX-5.1 27699
5 EX-23.2 d745029dex232.htm EX-23.2 1888
6 EX-FILING FEES d745029dexfilingfees.htm EX-FILING FEES 69478
7 GRAPHIC g745029g00m04.jpg GRAPHIC 41186
8 GRAPHIC g745029g0311175551409.jpg GRAPHIC 2345
9 GRAPHIC g745029g0311175552015.jpg GRAPHIC 1691
  Complete submission text file 0001193125-24-066903.txt   1019907
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277886 | Film No.: 24746657
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)